United Therapeutics Corporation (UTHR) Shareholders’ equity 2016–2025
United Therapeutics Corporation (UTHR) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.1BFY2025 · since FY2016: $1.9B → $7.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.1B | +10.1% |
| FY2024 | $6.4B | +7.7% |
| FY2023 | $6.0B | +24.8% |
| FY2022 | $4.8B | +21.2% |
| FY2021 | $4.0B | +16.6% |
| FY2020 | $3.4B | +22.1% |
| FY2019 | $2.8B | -0.3% |
| FY2018 | $2.8B | +32.7% |
| FY2017 | $2.1B | +13.5% |
| FY2016 | $1.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice